Gaurab Chakrabarti, MD, PhD, is the co-founder and CEO of Solugen, a company dedicated to decarbonizing the chemical industry. With a background in computational neuroscience and cancer biology, he has led Solugen to develop innovative enzymatic catalysts and scalable processes. Under his leadership, the company has grown significantly, achieving a $2 billion valuation and capturing substantial market share in various sectors.
Who is the CEO of Solugen?
Gaurab Chakrabarti, MD, PhD, is a physician-scientist who co-founded Solugen in 2016 with the mission to decarbonize the chemical industry. He holds a PhD in Cancer Biology and Enzymology and an MD from the University of Texas. Initially aiming for a career in medicine, his research into pancreatic cancer revealed parallels with chemical processing, inspiring him to pivot towards industrial biotechnology. Under his leadership, Solugen has developed innovative enzymatic catalysts and scalable processes, achieving significant market success and a $2 billion valuation. Gaurab's work emphasizes the use of biology to address complex industrial challenges, positioning Solugen as a leader in sustainable chemistry.
Work History
Gaurab Chakrabarti, MD, PhD, has an impressive work history that spans various prestigious institutions. Here is a summary of his professional journey:
- Brown University - Bachelor of Science (B.Sc.) in Neuroscience, Computational Biology (2006 to 2010)
- UT Southwestern Medical Center - Doctor of Medicine (M.D.) in Cancer Metabolism and Novel Therapeutics (2010 to 2017)
- UT Southwestern Medical Center - Doctor of Philosophy (Ph.D.) in Oncology and Cancer Biology (2012 to 2015)
- Y Combinator - Solugen (2017)
Education History
Gaurab Chakrabarti, MD, PhD, has a robust educational background that laid the foundation for his groundbreaking work in industrial biotechnology. He earned his Bachelor of Science in Neuroscience and Computational Biology from Brown University, where he studied from 2006 to 2010. Following this, he pursued a dual MD/PhD program at UT Southwestern Medical Center, focusing on Cancer Metabolism and Novel Therapeutics. He completed his MD in 2017 and his PhD in Oncology and Cancer Biology in 2015. This extensive education equipped him with the interdisciplinary knowledge and skills necessary to co-found Solugen and lead it to success.
When did Gaurab Chakrabarti, MD, PhD join Solugen?
Gaurab Chakrabarti, MD, PhD, co-founded Solugen in 2016 with the mission to decarbonize the chemical industry. Since its inception, he has served as the CEO, guiding the company through its innovative journey. As of 2024, Gaurab has been with Solugen for approximately 8 years, leading the company to significant milestones and market success. His leadership has been instrumental in developing groundbreaking enzymatic catalysts and scalable processes, positioning Solugen as a leader in sustainable chemistry.